U.S. flag

An official website of the United States government

NM_007327.4(GRIN1):c.1665G>T (p.Met555Ile) AND Intellectual disability, autosomal dominant 8

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 1, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002302855.2

Allele description [Variation Report for NM_007327.4(GRIN1):c.1665G>T (p.Met555Ile)]

NM_007327.4(GRIN1):c.1665G>T (p.Met555Ile)

Gene:
GRIN1:glutamate ionotropic receptor NMDA type subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.3
Genomic location:
Preferred name:
NM_007327.4(GRIN1):c.1665G>T (p.Met555Ile)
HGVS:
  • NC_000009.12:g.137162204G>T
  • NG_011507.1:g.28048G>T
  • NM_000832.7:c.1665G>T
  • NM_001185090.2:c.1728G>T
  • NM_001185091.2:c.1728G>T
  • NM_007327.4:c.1665G>TMANE SELECT
  • NM_021569.4:c.1665G>T
  • NP_000823.4:p.Met555Ile
  • NP_001172019.1:p.Met576Ile
  • NP_001172020.1:p.Met576Ile
  • NP_015566.1:p.Met555Ile
  • NP_067544.1:p.Met555Ile
  • NC_000009.11:g.140056656G>T
Protein change:
M555I
Molecular consequence:
  • NM_000832.7:c.1665G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001185090.2:c.1728G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001185091.2:c.1728G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007327.4:c.1665G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_021569.4:c.1665G>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Intellectual disability, autosomal dominant 8 (NDHMSD)
Synonyms:
Mental retardation, autosomal dominant 8; Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
Identifiers:
MONDO: MONDO:0013655; MedGen: C3280282; OMIM: 614254

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002588746Centre for Inherited Metabolic Diseases, Karolinska University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Nov 1, 2022)
de novoclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Centre for Inherited Metabolic Diseases, Karolinska University Hospital, SCV002588746.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
11not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Aug 5, 2023